Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value:
$26.56M
Total Bought:
$906.0K
Total Sold:
$11.04M
Net Transaction:
-$10.14M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
HilleVax, Inc.6,724,0006,724,0000$11.83M$13.92M52.40%+$2.08M
Ovid Therapeutics Inc.(OVID)7,531,9967,531,9960$8.89M$7.01M26.40%-$1.88M
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,1210$1.16M$1.42M5.33%+$253.7K
Equillium, Inc.(EQ)1,824,9771,824,9770$1.51M$1.37M5.15%-$146.0K
Shattuck Labs, Inc.(STTK)515,619515,6190$1.80M$623.9K2.35%-$1.18M
American Well Corporation(AMWL)77,73377,7330$736.9K$563.6K2.12%-$173.3K
Lyell Immunopharma, Inc.(LYEL)0823,317+823,317$0$526.9K1.98%+$526.9K
Turnstone Biologics Corp.895,824895,8240$499.0K$447.9K1.69%-$51.1K
Third Harmonic Bio, Inc.036,835+36,835$0$379.0K1.43%+$379.0K
Rani Therapeutics Holdings, Inc.(RANI)203,190203,1900$438.9K$278.4K1.05%-$160.5K
Standard BioTools Inc.(LAB)16,51516,5150$31.9K$28.9K0.11%-$3.0K
Wave Life Sciences, Inc.SHS(WVE)1,346,8920-1,346,892$11.04M$0—-$11.04M
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q4 2024 | TickerTrail